JERECZEK, BARBARA ALICJA
JERECZEK, BARBARA ALICJA
Dipartimento di Oncologia ed Emato-Oncologia
Stereotactic Radioablation for Ventricular Tachycardia in Patients Untreatable by Catheter Ablation: Evidence of Efficacy, Safety, and Impact on Coronary Arteries
2026 C. Carbucicchio, M. Schiavone, G. Piperno, M.E. Mancini, F. Cattani, M. Sabatino, A. Ferrari, A. Bonomi, F. Marchetti, L. Bianchini, E. Rondi, E. Ventura, S. Mushtaq, V. Catto, R. Orecchia, G. Pompilio, C. Tondo, G. Pontone, B.A. Jereczek-Fossa
Predictive Modelling of Service Building and Users Mobility Related Energy Consumption Through Machine Learning and Graph Based Analysis
2026 V. Bellandi, S. Siccardi, M.G. Vincini, F. Mastroleo, G. Marvaso, B.A. Jereczek‐fossa, E. Damiani
Harnessing Baseline Radiomic Features in Early-Stage NSCLC: What Role in Clinical Outcome Modeling for SBRT Candidates?
2025 S. Volpe, M.G. Vincini, M. Zaffaroni, A. Gaeta, S. Raimondi, G. Piperno, J. Franzetti, F. Colombo, A.M. Camarda, F. Mastroleo, F. Botta, L. Spaggiari, S. Gandini, M. Guckenberger, R. Orecchia, M. Casiraghi, B.A. Jereczek-Fossa
Stereotactic body radiotherapy combined with immunotherapy or targeted therapy: a screenshot from Italy on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)
2025 G. Corrao, G. Marvaso, M. Zaffaroni, M.G. Vincini, S. Badellino, P. Borghetti, F. Cuccia, M. Federico, G. Montesi, A. Pontoriero, C. Franzese, M. Loi, B.A. Jereczek-Fossa, M. Scorsetti
A new application of computed tomography: stereotactic radiotherapy in the treatment of ventricular arrhythmias
2025 M.E. Mancini, F. Marchetti, S. Mushtaq, F. Cannata, M. Schiavone, C. Tondo, G. Piperno, B.A. Jereczek-Fossa, C. Carbucicchio, G. Pontone
Thermal ablation for local tumor recurrence after previous partial nephrectomy: Perioperative and oncological outcomes
2025 C. Vaccaro, F.A. Mistretta, M.L. Piccinelli, E. Lievore, L.M.I. Jannello, M. Fontana, M. Tozzi, P. Della Vigna, G. Bonomo, G. Varano, F. Mastroleo, G. Marvaso, B.A. Jereczek-Fossa, S. Luzzago, F. Orsi, G. Musi
Exploratory analysis of the professional quality of life in an Italian radiotherapy department: The role of empathy and alexithymia
2025 T. Burla, M. Zaffaroni, G. Marvaso, K. Mazzocco, G. Galli, M.G. Vincini, F. Mastroleo, M. Sarra Fiore, G. Pravettoni, B.A. Jereczek-Fossa
Salvage Radiotherapy Following Nonradiotherapy Ablative Techniques for Primary Prostate Cancer: A Systematic Review and Meta-analysis
2025 O. Mohamad, L. Mose, M. Ahmadsei, R. Kouzy, C. Zamboglou, L. Nicosia, F. Alongi, T. Zilli, S. Arcangeli, G. Marvaso, B.A. Jereczek-Fossa, M. Guckenberger, D.M. Aebersold, M. Shelan
Interventional stereotactic radiotherapy (brachytherapy) for unresected brain metastases: Systematic review of outcome and toxicity
2025 M. Bilski, F. Mastroleo, L. Kuncman, P. Rogowski, S. Durante, C. Putzu, A. Chyrek, G. Marvaso, B. Fionda, L. Tagliaferii, J. Fijuth, A. Vavassori, R. Tolakanahalli, B.A. Jereczek-Fossa, R. Kotecha
Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation Therapy
2025 F. Mastroleo, R. Villa, M. Zaffaroni, M.G. Vincini, C. Franzese, L. Nicosia, F. Matrone, A. Donofrio, A. Magli, L. Triggiani, S. Barra, G. Timon, M. Augugliaro, V. Burgio, G. Francolini, M. Hasterok, M. Miszczyk, N. Simoni, C. Spatola, F. Alongi, S. Arcangeli, M. Scorsetti, G. Marvaso, B.A. Jereczek-Fossa
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial
2025 G. Marvaso, G. Corrao, M. Zaffaroni, M.G. Vincini, C. Lorubbio, S. Gandini, C. Fodor, S. Netti, D. Zerini, S. Luzzago, F.A. Mistretta, K. Venetis, G. Cursano, T. Burla, K. Mazzocco, F. Cattani, G. Petralia, N. Fusco, G. Pravettoni, G. Musi, O. De Cobelli, C. Tang, P. Ost, D.A. Palma, R. Orecchia, B.A. Jereczek-Fossa
Understanding the role of nerves in head and neck cancers - a review
2025 K. Rutkowski, M. Gola, J. Godlewski, A. Starzynska, G. Marvaso, F. Mastroleo, M. Giulia Vincini, A. Porazzi, M. Zaffaroni, B.A. Jereczek-Fossa
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care
2025 V. Murthy, G. Marvaso, B.A. Jereczek-Fossa, S.A. Thoma, M. Vogel, N.-. Schmidt-Hegemann, M. Shelan, S. Siva, T. Hoelscher, A.U. Kishan, J.C. Peeken, S. Gillessen, M. Guckenberger, K. Herrmann, W.P. Fendler, T. Zilli, S.K.B. Spohn, C. Zamboglou
RadiOnCOVID: Multicentric Analysis of the Impact of COVID-19 on Patients Undergoing Radiation Therapy in Italy
2025 A.E. Guerini, G. Marvaso, S. Tonoli, G. Corrao, M.A. Teriaca, M. Sepulcri, M. Scricciolo, A. Gava, S. Montrone, N. Giaj-Levra, B.N. Chiorda, G. Mantello, F. Fiorica, S. Borghesi, L. Belgioia, A. Caroli, A. Fiorentino, B.A. Jereczek-Fossa, S.M. Magrini, M. Buglione
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719)
2025 G. Francolini, N. Bertini, V. Di Cataldo, P. Garlatti, M. Aquilano, S. Caini, A. Bruni, G. Ingrosso, R.M. D'Angelillo, L. Tagliaferri, M. Augugliaro, L. Triggiani, S. Parisi, G. Timon, F. Arcidiacono, G. Marvaso, B.A. Jereczek-Fossa, A. Lancia, C. Franzese, F. Alongi, G. Simontacchi, D. Greto, P. Bonomo, M. Loi, G. Frosini, L. Burchini, I. Desideri, I. Meattini, R.K. Valicenti, L. Livi
Precision Radiotherapy for Kidney Cancer: A Rising Ally in Multidisciplinary Care
2025 B.A. Jereczek-Fossa, F. Mastroleo, G. Marvaso
Metastasis-directed Therapy in the Management of Urothelial Carcinoma: A Systematic Review and Meta-analysis
2025 M. Miszczyk, M. Bilski, T. Koi, K. Konat-Baska, A. Suleja, T. Fazekas, A. Matsukawa, I. Tsuboi, R. Schulz, P. Rajwa, E. Laukhtina, M.R. Hassler, G. Marvaso, P. Sargos, P. Ost, G. Ploussard, B. Jereczek-Fossa, M. Roupret, P. Chlosta, P.I. Karakiewicz, M. Babjuk, J.Y.-. Teoh, M. Moschini, P. Gontero, S.F. Shariat
Metastasis-directed stereotactic radiotherapy and systemic treatment continuation for patients with oligoprogressive metastatic breast cancer
2025 M. Milano, C. Valenza, A. Ferrari, S. Gandini, D. Trapani, C. Santoro, E. Battaiotto, A. Carnevale Schianca, E. Giordano, J. Katrini, G. Castellano, B. Taurelli Salimbeni, M.C. Leonardi, S. Dicuonzo, C. Criscitiello, N. Bianco, S. Dellapasqua, E. Munzone, G. Curigliano, M. Colleoni, B.A. Jereczek-Fossa
Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study
2025 F. Mastroleo, R. Villa, M. Zaffaroni, M.G. Vincini, C. Franzese, L. Nicosia, F. Matrone, A. Donofrio, A. Magli, L. Triggiani, S. Barra, G. Timon, M. Augugliaro, V. Burgio, G. Francolini, M. Hasterok, M. Miszczyk, N. Simoni, C. Spatola, F. Alongi, S. Arcangeli, M. Scorsetti, G. Marvaso, B.A. Jereczek-Fossa
Coronary artery calcium and cardiovascular risk factors analysis after radiotherapy for breast cancer (the CLARIFIER: a gender-based preventive medicine study)
2025 D. Trabattoni, M.C. Leonardi, M.E. Mancini, B.A. Jereczek-Fossa, F. Cattani, G. Santagostino Baldi, A. Bonomi, A. Galotta, S. Mushtaq, A. Annoni, D. Alio, M.G. Vincini, C.I. Fodor, L. La Grutta, P. Montorsi, G. Pontone